Pancreatic Cancer Biomarker Study

NCT04143152 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2024-04-23

No results posted yet for this study

Summary

This is a non-treatment, blood collection study to evaluate biomarker panels for the diagnosis and prognosis of pancreatic cancer.

Conditions

  • Pancreatic Adenocarcinoma

Sponsors & Collaborators

  • Spectrum Health Hospitals

    collaborator OTHER
  • Mercy Health

    collaborator OTHER
  • Van Andel Research Institute

    lead OTHER

Principal Investigators

  • Brian Haab, PhD · Van Andel Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-08-31
Completion
2024-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04143152 on ClinicalTrials.gov